Figure 1From: Lenvatinib, an angiogenesis inhibitor targeting VEGFR/FGFR, shows broad antitumor activity in human tumor xenograft models associated with microvessel density and pericyte coverageKinase inhibitory activity and antiangiogenic activity of lenvatinib in vitro. A: Chemical structure of lenvatinib. B: Ki values of lenvatinib. C: Effects of lenvatinib on the VEGF-induced proliferation and tube formation of HUVEC. D: Effects on the FGF-induced proliferation and tube formation of HUVEC. sTF assay; sandwich tube formation assay.Back to article page